Vertex halts VX-264 trials after missing efficacy goals but continues advancing zimislecel, a potential treatment for severe ...
Hosted on MSN1mon
FDA approves first new non-opioid painkiller in decades, and it's from a MA company.Vertex Pharmaceuticals is a biotech company based in Boston. Its headquarters are in the Seaport neighborhood, and it also has a research site in Cambridge's Kendall Square. The company also has ...
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $478.12, a high ...
Moderna, Inc.; and Entrada Therapeutics, Inc. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.
With a market cap of $124.9 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a global biotechnology company. The Boston, Massachusetts-based company engages in developing and ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback